Publication: Dihydrofolate-reductase mutations in plasmodium knowlesi appear unrelated to selective drug pressure from putative human-to-human transmission in Sabah, Malaysia
1
Issued Date
2016-03-01
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-84962243417
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.11, No.3 (2016)
Suggested Citation
Matthew J. Grigg, Bridget E. Barber, Jutta Marfurt, Mallika Imwong, Timothy William, Elspeth Bird, Kim A. Piera, Ammar Aziz, Usa Boonyuen, Christopher J. Drakeley, Jonathan Cox, Nicholas J. White, Qin Cheng, Tsin W. Yeo, Sarah Auburn, Nicholas M. Anstey Dihydrofolate-reductase mutations in plasmodium knowlesi appear unrelated to selective drug pressure from putative human-to-human transmission in Sabah, Malaysia. PLoS ONE. Vol.11, No.3 (2016). doi:10.1371/journal.pone.0149519 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/40970
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dihydrofolate-reductase mutations in plasmodium knowlesi appear unrelated to selective drug pressure from putative human-to-human transmission in Sabah, Malaysia
Other Contributor(s)
Menzies School of Health Research
Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit
Mahidol University
Queen Elizabeth Hospital
Jesselton Medical Centre
London School of Hygiene & Tropical Medicine
Royal Darwin Hospital
Nanyang Technological University
Australian Army Malaria Institute
QIMR Berghofer Medical Research Institute
Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit
Mahidol University
Queen Elizabeth Hospital
Jesselton Medical Centre
London School of Hygiene & Tropical Medicine
Royal Darwin Hospital
Nanyang Technological University
Australian Army Malaria Institute
QIMR Berghofer Medical Research Institute
Abstract
© 2016 Grigg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background Malaria caused by zoonotic Plasmodium knowlesi is an emerging threat in Eastern Malaysia. Despite demonstrated vector competency, it is unknown whether human-to-human (HH) transmission is occurring naturally. We sought evidence of drug selection pressure from the antimalarial sulfadoxine-pyrimethamine (SP) as a potential marker of H-H transmission. Methods The P. knowlesi dihdyrofolate-reductase (pkdhfr) gene was sequenced from 449 P. knowlesi malaria cases from Sabah (Malaysian Borneo) and genotypes evaluated for association with clinical and epidemiological factors. Homology modelling using the pvdhfr template was used to assess the effect of pkdhfr mutations on the pyrimethamine binding pocket. Results Fourteen non-synonymous mutations were detected, with the most common being at codon T91P (10.2%) and R34L (10.0%), resulting in 21 different genotypes, including the wild- type, 14 single mutants, and six double mutants. One third of the P. knowlesi infections were with pkdhfr mutants; 145 (32%) patients had single mutants and 14 (3%) had doublemutants. In contrast, among the 47 P. falciparum isolates sequenced, three pfdhfr genotypes were found, with the double mutant 108N+59R being fixed and the triple mutants 108N+59R+51I and 108N+59R+164L occurring with frequencies of 4% and 8%, respectively. Two non-random spatio-temporal clusters were identified with pkdhfr genotypes. There was no association between pkdhfr mutations and hyperparasitaemia or malaria severity, both hypothesized to be indicators of H-H transmission. The orthologous loci associated with resistance in P. falciparum were not mutated in pkdhfr. Subsequent homology modelling of pkdhfr revealed gene loci 13, 53, 120, and 173 as being critical for pyrimethamine binding, however, there were no mutations at these sites among the 449 P. knowlesi isolates. Conclusion Although moderate diversity was observed in pkdhfr in Sabah, there was no evidence this reflected selective antifolate drug pressure in humans.